Notable Upgrades: Citigroup (C), Vertex Pharma (VRTX), AbbVie (ABBV), Vascular Biogenics (VBLT), Medivation (MDVN)

Analysts at Jefferies are out with a report this morning upgrading shares of Citigroup Inc. (C) with a ‘Buy’ from ‘Hold’ rating, citing an attractive risk/reward profile despite potential short term headwinds. The name was also upgraded to ‘Outperform’ from ‘Neutral’ at Credit Suisse (CS). On valuation measures, Citi shares are currently priced at 12.45x […] View the full post at: Notable Upgrades: Citigroup (C), Vertex Pharma (VRTX), AbbVie (ABBV), Vascular Biogenics (VBLT), Medivation (MDVN) Related posts: American Innovation in Health Care is Alive and Well GM, Citigroup Kicked out of Dow Jones Japan’s Shionogi To Acquire Sciele Pharma (SCRX) for $1.42 Billion